Condition: Recent Onset type1 Diabetes · Sponsor: Dompé Farmaceutici S.p.A
Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the progression of T1D in adolescent and adult patients. The safety of ladarixin in the specific clinical setting will be also evaluated.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham (UAB) - The Kirklin Clinic (TKC) - Multidisciplinary Comprehensive Diabetes Clinic (MCDC) | Birmingham, Alabama, United States | — |
| Phoenician Centers for Research and Innovation | Phoenix, Arizona, United States | — |
| University of California San Diego | La Jolla, California, United States | — |
| Center of Excellence in Diabetes & Endocrinology (CEDE) | Sacramento, California, United States | — |
| University of Colorado School of Medicine - Barbara Davis Center for Childhood Diabetes (BDC) - Specialty Clinic | Aurora, Colorado, United States | — |
| Christiana Care Endocrinology Specialists | Newark, Delaware, United States | — |
| Diabetes Care Center - Hudson | Hudson, Florida, United States | — |
| Global Life Research Network | Miami, Florida, United States | — |
| AdventHealth (Florida Hospital) - Diabetes Institute - Orlando | Orlando, Florida, United States | — |
| Atlanta Diabetes Associates (ADA) | Atlanta, Georgia, United States | — |
| The University of Chicago | Chicago, Illinois, United States | — |
| Prairie Education and Research Cooperative d/b/a Central Illinois Diabetes and Clinical | Springfield, Illinois, United States | — |
+ 45 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04628481